The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3)
Open accessAbstract
Mucormycosis is an emerging cause of infectious morbidity and mortality in patients with hematologic malignancies. However, there are no recommendations to guide diagnosis and management. The European Conference on Infections in Leukemia assigned experts in hematology and infectious diseases to develop evidence-based recommendations for the diagnosis and treatment of mucormycosis. The guidelines were developed using the evidence criteria set forth by the American Infectious Diseases Society and the key recommendations are summarized here. In the absence of validated biomarkers, the diagnosis of mucormycosis relies on histology and/or detection of the organism by culture from involved sites with identification of the isolate at the species level (no grading). Antifungal chemotherapy, control of the underlying predisposing condition, and surgery are the cornerstones of management (level A II). Options for first-line chemotherapy of mucormycosis include liposomal amphotericin B and amphotericin B lipid complex (level B II). Posaconazole and combination therapy of liposomal amphotericin B or amphotericin B lipid complex with caspofungin are the options for second line-treatment (level B II). Surgery is recommended for rhinocerebral and skin and soft tissue disease (level A II). Reversal of underlying risk factors (diabetes control, reversal of neutropenia, discontinuation/taper of glucocorticosteroids, reduction of immunosuppressants, discontinuation of deferroxamine) is important in the treatment of mucormycosis (level A II). The duration of antifungal chemotherapy is not defined but guided by the resolution of all associated symptoms and findings (no grading). Maintenance therapy/secondary prophylaxis must be considered in persistently immunocompromised patients (no grading).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
Roden, M. M., Zaoutis, T. E., Buchanan, W. L., Knudsen, T. A., Sarkisova, T. A., Schaufele, R. L., Sein, M., Sein, T., Chiou, C. C., Chu, J. H., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/432579 · Cited by 3,044
Kontoyiannis, D. P., Marr, K. A., Park, B. J., Alexander, B. D., Anaissie, E. J., Walsh, T. J., Ito, J., Andes, D. R., Baddley, J. W., Brown, J. M., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651263 · Cited by 1,456
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
Marr, K. A., Carter, R. A., Crippa, F., Wald, A., & Corey, L. (2002) · Clinical Infectious Diseases · doi:10.1086/339202 · Cited by 1,448
(2006) · PubMed · Cited by 906
Chamilos, G., Lewis, R. E., & Kontoyiannis, D. P. (2008) · Clinical Infectious Diseases · doi:10.1086/590004 · Cited by 826
Neofytos, D., Horn, D., Anaissie, E., Steinbach, W., Olyaei, A., Fishman, J., Pfaller, M., Chang, C., Webster, K., & Marr, K. (2009) · Clinical Infectious Diseases · doi:10.1086/595846 · Cited by 801
Walsh, T. J., Raad, I., Patterson, T. F., Chandrasekar, P., Donowitz, G. R., Graybill, R., Greene, R. E., Hachem, R., Hadley, S., Herbrecht, R., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/508774 · Cited by 752
Self-citationCornely, O. A., Maertens, J., Bresnik, M., Ebrahimi, R., Ullmann, A. J., Bouza, E., Heussel, C. P., Lortholary, O., Rieger, C., Boehme, A., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/514341 · Cited by 751
Self-citationSkiada, A., Pagano, L., Groll, A., Zimmerli, S., Dupont, B., Lagrou, K., Lass-Florl, C., Bouza, E., Klimko, N., Gaustad, P., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03456.x · Cited by 748
Self-citation(2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511722240 · Cited by 648
Walsh, T. J., Hiemenz, J. W., Seibel, N. L., Perfect, J. R., Horwith, G., Lee, L., Silber, J. L., DiNubile, M. J., Reboli, A., Bow, E., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/516353 · Cited by 629
Posaconazole Is Effective as Salvage Therapy in Zygomycosis: A Retrospective Summary of 91 Cases
van Burik, J.-A. H., Hare, R. S., Solomon, H. F., Corrado, M. L., & Kontoyiannis, D. P. (2006) · Clinical Infectious Diseases · doi:10.1086/500212 · Cited by 615
Espinel-Ingroff, A. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.10.2950-2956.1998 · Cited by 576
Posaconazole as Salvage Therapy for Zygomycosis
Greenberg, R. N., Mullane, K., van Burik, J.-A. H., Raad, I., Abzug, M. J., Anstead, G., Herbrecht, R., Langston, A., Marr, K. A., Schiller, G., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.126-133.2006 · Cited by 555
Self-citationRecent Advances in the Management of Mucormycosis: From Bench to Bedside
Spellberg, B., Walsh, T. J., Kontoyiannis, D. P., Edwards, Jr., & Ibrahim, A. S. (2009) · Clinical Infectious Diseases · doi:10.1086/599105 · Cited by 548
A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005-2007)
Lanternier, F., Dannaoui, E., Morizot, G., Elie, C., Garcia-Hermoso, D., Huerre, M., Bitar, D., Dromer, F., Lortholary, O., & the French Mycosis Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir880 · Cited by 527
Self-citationZygomycosis in the 1990s in a Tertiary-Care Cancer Center
Kontoyiannis, D. P., Wessel, V. C., Bodey, G. P., & Rolston, K. V. I. (2000) · Clinical Infectious Diseases · doi:10.1086/313803 · Cited by 521
Combination Polyene‐Caspofungin Treatment of Rhino‐Orbital‐Cerebral Mucormycosis
Reed, C., Bryant, R., Ibrahim, A. S., Edwards, Jr., Filler, S. G., Goldberg, R., & Spellberg, B. (2008) · Clinical Infectious Diseases · doi:10.1086/589857 · Cited by 494
Survival factors in rhino-orbital-cerebral mucormycosis
Yohai, R. A., Bullock, J. D., Aziz, A. A., & Markert, R. J. (1994) · Survey of Ophthalmology · doi:10.1016/s0039-6257(05)80041-4 · Cited by 492
Chamilos, G., Luna, M. A., Lewis, R. E., Bodey, G. P., Chemaly, R. F., Tarrand, J. J., Safdar, A., RAAD, I. I., & Kontoyiannis, D. P. (2006) · PubMed · Cited by 479
Segal, B. H., Herbrecht, R., Stevens, D. A., Ostrosky‐Zeichner, L., Sobel, J., Viscoli, C., Walsh, T. J., Maertens, J., Patterson, T. F., Perfect, J. R., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/590566 · Cited by 468
Self-citationPulmonary mucormycosis: Results of medical and surgical therapy
Tedder, M., Spratt, J. A., Anstadt, M. P., Hegde, S. S., Tedder, S. D., & Lowe, J. E. (1994) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(94)90243-7 · Cited by 452
Increasing Incidence of Zygomycosis (Mucormycosis), France, 1997–2006
Bitar, D., Van Cauteren, D., Lanternier, F., Dannaoui, E., Che, D., Dromer, F., Desenclos, J.-C., & Lortholary, O. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1509.090334 · Cited by 429
Self-citationMarty, F. M., Cosimi, L. A., & Baden, L. R. (2004) · New England Journal of Medicine · doi:10.1056/nejm200402263500923 · Cited by 426
Walsh, T. J., Goodman, J. L., Pappas, P., Bekersky, I., Buell, D. N., Roden, M., Barrett, J., & Anaissie, E. J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3487-3496.2001 · Cited by 401
The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus
Chakrabarti, A., Das, A., Mandal, J., Shivaprakash, M. R., George, V. K., Tarai, B., Rao, P., Panda, N., Verma, S. C., & Sakhuja, V. (2006) · Medical Mycology · doi:10.1080/13693780500464930 · Cited by 376
Groll, A. H., Giri, N., Petraitis, V., Petraitiene, R., Candelario, M., Bacher, J. S., Piscitelli, S. C., & Walsh, T. J. (2000) · The Journal of Infectious Diseases · doi:10.1086/315643 · Cited by 373
Self-citationPulmonary Mucormycosis: The Last 30 Years
Lee, F. Y. W., Mossad, S. B., & Adal, K. A. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.12.1301 · Cited by 369
Predictors of Pulmonary Zygomycosis versus Invasive Pulmonary Aspergillosis in Patients with Cancer
Chamilos, G., Marom, E. M., Lewis, R. E., Lionakis, M. S., & Kontoyiannis, D. P. (2005) · Clinical Infectious Diseases · doi:10.1086/430710 · Cited by 369
Sun, Q. N., Fothergill, A. W., McCarthy, D. I., Rinaldi, M. G., & Graybill, J. R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1581-1582.2002 · Cited by 365
Garcia‐Vidal, C., Upton, A., Kirby, K. A., & Marr, K. A. (2008) · Clinical Infectious Diseases · doi:10.1086/591969 · Cited by 364
Kwon-Chung, K. J. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir864 · Cited by 347
In vitro susceptibilities of zygomycetes to conventional and new antifungals
Dannaoui, E. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg020 · Cited by 314
Spellberg, B., Ibrahim, A. S., Chin-Hong, P. V., Kontoyiannis, D. P., Morris, M. I., Perfect, J. R., Fredricks, D., & Brass, E. P. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr375 · Cited by 308
The iron chelator deferasirox protects mice from mucormycosis through iron starvation
Ibrahim, A. S., Gebermariam, T., Fu, Y., Lin, Husseiny, M. I., French, S. W., Schwartz, J., Skory, C. D., Edwards, J. E., & Spellberg, B. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32338 · Cited by 308
Mucormycosis in hematologic patients.
Pagano, L., Offidani, M., Fianchi, L., Nosari, A., Candoni, A., Picardi, M., Corvatta, L., D’Antonio, D., Girmenia, C., Martino, P., et al. (2004) · PubMed · Cited by 302
Self-citationAlmyroudis, N. G., Sutton, D. A., Fothergill, A. W., Rinaldi, M. G., & Kusne, S. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00452-07 · Cited by 285
Almyroudis, N. G., Sutton, D. A., Linden, P., Rinaldi, M. G., Fung, J., & Kusne, S. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01496.x · Cited by 277
Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment
Ibrahim, A. S., Spellberg, B., & Edwards, J. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283165fd1 · Cited by 264
Invasive zygomycosis in India: experience in a tertiary care hospital
Chakrabarti, A., Chatterjee, S. S., Das, A., Panda, N., Shivaprakash, M. R., Kaur, A., Varma, S. C., Singhi, S., Bhansali, A., & Sakhuja, V (2009) · Postgraduate Medical Journal · doi:10.1136/pgmj.2008.076463 · Cited by 244
Singh, N., Aguado, J. M., Bonatti, H., Forrest, G., Gupta, K. L., Safdar, N., John, G. T., Pursell, K. J., Muñoz, P., Patel, R., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/605445 · Cited by 233
Self-citationTrifilio, S., Singhal, S., Williams, S., Frankfurt, O., Gordon, L., Evens, A., Winter, J., Tallman, M., Pi, J., & Mehta, J. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705754 · Cited by 229
Improved Outcome of Zygomycosis in Patients with Hematological Diseases?
Gleissner, B., Schilling, A., Anagnostopolous, I., Siehl, I., & Thiel, E. (2004) · Leukemia & Lymphoma · doi:10.1080/10428190310001653691 · Cited by 227
Zygomycosis in Children: A Systematic Review and Analysis of Reported Cases
Zaoutis, T. E., Roilides, E., Chiou, C. C., Buchanan, W. L., Knudsen, T. A., Sarkisova, T. A., Schaufele, R. L., Sein, M., Sein, T., Prasad, P. A., et al. (2007) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318062115c · Cited by 225
Lass-Florl, C., Resch, G., Nachbaur, D., Mayr, A., Gastl, G., Auberger, J., Bialek, R., & Freund, M. C. (2007) · Clinical Infectious Diseases · doi:10.1086/521245 · Cited by 221
Stevens, D. A., Espiritu, M., & Parmar, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3407-3411.2004 · Cited by 217
Rickerts, V., Mousset, S., Lambrecht, E., Tintelnot, K., Schwerdtfeger, R., Presterl, E., Jacobi, V., Just-Nubling, G., & Bialek, R. (2007) · Clinical Infectious Diseases · doi:10.1086/512812 · Cited by 209
Ibrahim, A. S., Bowman, J. C., Avanessian, V., Brown, K., Spellberg, B., Edwards, J. E., & Douglas, C. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.721-727.2005 · Cited by 207
Forty-one recent cases of invasive zygomycosis from a global clinical registry
Ruping, M. J. G. T., Heinz, W. J., Kindo, A. J., Rickerts, V., Lass-Florl, C., Beisel, C., Herbrecht, R., Roth, Y., Silling, G., Ullmann, A. J., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp430 · Cited by 201
Self-citationNithyanandam, S., Jacob, M. S., Battu, R., Thomas, R. K., Correa, M. A. R., & D’Souza, O. (2003) · PubMed · Cited by 197
Zygomycosis: conventional laboratory diagnosis
Lass-Flörl, C. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02999.x · Cited by 187
Spellberg, B., Fu, Y., Edwards, J. E., & Ibrahim, A. S. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.830-832.2005 · Cited by 186
In Vivo Activity of Posaconazole against Mucor spp. in an Immunosuppressed-Mouse Model
Sun, Q. N., Najvar, L. K., Bocanegra, R., Loebenberg, D., & Graybill, J. R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2310-2312.2002 · Cited by 184
Combination Echinocandin-Polyene Treatment of Murine Mucormycosis
Ibrahim, A. S., Gebremariam, T., Fu, Y., Edwards, J. E., & Spellberg, B. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01458-07 · Cited by 180
Combination Therapy for Mucormycosis: Why, What, and How?
Spellberg, B., Ibrahim, A., Roilides, E., Lewis, R. E., Lortholary, O., Petrikkos, G., Kontoyiannis, D. P., & Walsh, T. J. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir885 · Cited by 171
Self-citationGranulocyte-Macrophage Colony-stimulating Factor-activated Signaling Pathways in Human Neutrophils
Al-Shami, A., Mahanna, W., & Naccache, P. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.2.1058 · Cited by 170
Gil‐Lamaignere, C., Simitsopoulou, M., Roilides, E., Maloukou, A., Winn, R. M., & Walsh, T. J. (2005) · The Journal of Infectious Diseases · doi:10.1086/428503 · Cited by 169
Activity of Posaconazole in Treatment of Experimental Disseminated Zygomycosis
Dannaoui, E., Meis, J. F. G. M., Loebenberg, D., & Verweij, P. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3647-3650.2003 · Cited by 159
The Safety and Efficacy of Amphotericin B Colloidal Dispersion in the Treatment of Invasive Mycoses
Oppenheim, B. A., Herbrecht, R., & Kusne, S. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.5.1145 · Cited by 146
Self-citationTreatment of 21 Cases of Invasive Mucormycosis with Amphotericin B Colloidal Dispersion
Herbrecht, R., Letscher‐Bru, V., Bowden, R. A., Kusne, S., Anaissie, E. J., Graybill, J. R., Noskin, G. A., Oppenheim, B. A., Andrès, E., & Pietrelli, L. A. (2001) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960100528 · Cited by 142
Self-citationvan Burik, J. H., Hare, R. S., Solomon, H. F., Corrado, M. L., & Kontoyiannis, D. P. (2006) · Clinical Infectious Diseases · Cited by 140
Deferasirox, an Iron-Chelating Agent, as Salvage Therapy for Rhinocerebral Mucormycosis
Reed, C., Ibrahim, A. S., Edwards, J. E., Walot, I., & Spellberg, B. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01065-06 · Cited by 136
Liles, W. C., Huang, J. E., van Burik, J. H., Bowden, R. A., & Dale, D. C. (1997) · The Journal of Infectious Diseases · doi:10.1086/513961 · Cited by 135
Rhino-Orbital-Cerebral Zygomycosis in Solid Organ Transplant Recipients
Sun, H., Forrest, G. N., Gupta, K. L., Aguado, J. M., Lortholary, O., Juliá, M. B., Safdar, N., Patel, R., Kusne, S., & Singh, N. (2010) · Transplantation · doi:10.1097/tp.0b013e3181dde8fc · Cited by 122
Self-citationCryptococcosis in Patients with Cancer
Kontoyiannis, D. P., Ludwig‐Peitsch, W., Reddy, B. T., Whimbey, E. E., Han, X.-Y., Bodey, G. P., & Rolston, K. V. (2001) · Clinical Infectious Diseases · doi:10.1086/320524 · Cited by 117
Posaconazole: clinical pharmacology and potential for management of fungal infections
Groll, A. H., & Walsh, T. J. (2005) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.3.4.467 · Cited by 114
Self-citationJensen, H. E., Salonen, J. H., & Ekfors, T. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199701)181:1<100::aid-path100>3.0.co;2-o · Cited by 104
Posaconazole Mono- or Combination Therapy for Treatment of Murine Zygomycosis
Ibrahim, A. S., Gebremariam, T., Schwartz, J. A., Edwards, J. E., & Spellberg, B. J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01124-08 · Cited by 104
Ibrahim, A. S., Avanesian, V., Spellberg, B. J., & Edwards, J. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3343-3344.2003 · Cited by 99
Pagano, L., Valentini, C. G., Posteraro, B., Girmenia, C., Ossi, C. M., Pan, A. S., Candoni, A., Nosari, A., Riva, M., Cattaneo, C. M., et al. (2009) · Journal of Chemotherapy · doi:10.1179/joc.2009.21.3.322 · Cited by 98
Self-citationRodríguez, M. M., Serena, C., Mariné, M., Pastor, F. J., & Guarro, J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00628-08 · Cited by 97
Gaviria, J. M., van Burik, J. H., Dale, D. C., Root, R. K., & Liles, W. C. (1999) · The Journal of Infectious Diseases · doi:10.1086/314679 · Cited by 95
Safety and Outcomes of Open-Label Deferasirox Iron Chelation Therapy for Mucormycosis
Spellberg, B. J., Andes, D. R., Perez, M., Anglim, A. M., Bonilla, H. F., Mathisen, G. E., Walsh, T. J., & Ibrahim, A. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00361-09 · Cited by 93
Dannaoui, É., Schwarz, P., Slaný, M., Loeffler, J., Jorde, A. T., Cuenca‐Estrella, M., Hauser, P. M., Shrief, R., Huerre, M., Freiberger, T., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02319-09 · Cited by 92
Self-citationXhaard, A., Lanternier, F., Porcher, R., Dannaoui, É., Bergeron, A., Clement, L., Lacroix, C., Herbrecht, R., Legrand, F., Mohty, M., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03908.x · Cited by 86
Self-citationGranulocyte-Macrophage Colony-stimulating Factor-activated Signaling Pathways in Human Neutrophils
Al-Shami, A., & Naccache, P. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.9.5333 · Cited by 83
Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases
Shoham, S., Magill, S. S., Merz, W. G., Gonzalez, C. E., Seibel, N. L., Buchanan, W. L., Knudsen, T. A., Sarkisova, T. A., & Walsh, T. J. (2010) · Medical Mycology · doi:10.3109/13693780903311944 · Cited by 83
Pulmonary Zygomycosis in Solid Organ Transplant Recipients in the Current Era
Sun, H., Aguado, J. M., Bonatti, H., Forrest, G. N., Gupta, K. L., Safdar, N., John, G. T., Pursell, K. J., Muñóz, P., Patel, R., et al. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02754.x · Cited by 82
Self-citationLewis, R. E., Albert, N. D., Liao, G., Hou, J., Prince, R. A., & Kontoyiannis, D. P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01222-09 · Cited by 82
Perkhofer, S., Lechner, V., & Lass‐Flörl, C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01530-08 · Cited by 81
Garcia‐Diaz, J., Palau, L. A., & Pankey, G. A. (2001) · Clinical Infectious Diseases · doi:10.1086/320767 · Cited by 76
Kume, H., Yamazaki, T., Abe, M., TANUMA, H., Okudaira, M., & Okayasu, I. (2003) · Pathology International · doi:10.1046/j.1440-1827.2003.01548.x · Cited by 74
Hyperbaric oxygen therapy and other adjunctive treatments for zygomycosis
Tragiannidis, A., & Groll, A. H. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02986.x · Cited by 73
Self-citationArıkan, S., Sancak, B., Alp, Ş., Hasçelik, G., & McNicholas, P. M. (2008) · Medical Mycology · doi:10.1080/13693780801975576 · Cited by 70
Posaconazole Enhances the Activity of Amphotericin B against Hyphae of Zygomycetes In Vitro
Perkhofer, S., Locher, M., Cuenca‐Estrella, M., Rüchel, R., Würzner, R., Dierich, M. P., & Lass‐Flörl, C. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00492-08 · Cited by 67
Torres-Narbona, M., Guinea, J., Martínez-Alarcón, J., Peláez, T., & Bouza, E. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01539-06 · Cited by 66
Verweij, P. E., González, G. M., Wiederhold, N. P., Lass‐Flörl, C., Warn, P. A., Heep, M., Ghannoum, M. A., & Guinea, J. (2009) · Journal of Chemotherapy · doi:10.1179/joc.2009.21.3.272 · Cited by 64
Comparison of Lipid Amphotericin B Preparations in Treating Murine Zygomycosis
Ibrahim, A. S., Gebremariam, T., Husseiny, M. I., Stevens, D. A., Fu, Y., Edwards, J. E., & Spellberg, B. J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01488-07 · Cited by 64
Rapid Susceptibility Testing of Medically Important Zygomycetes by XTT Assay
Antachopoulos, C., Meletiadis, J., Roilides, E., Sein, T., & Walsh, T. J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.2.553-560.2006 · Cited by 61
Singh, J., Rimek, D., & Kappe, R. (2005) · Mycoses · doi:10.1111/j.1439-0507.2005.01132.x · Cited by 55
Efficacy of Antifungal Therapy in a Nonneutropenic Murine Model of Zygomycosis
Dannaoui, É., Mouton, J. W., Meis, J. F. G. M., & Verweij, P. E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1953-1959.2002 · Cited by 49
Survival Factors in Rhino-Orbital-Cerebral Mucormycosis
Barker, D. E. (1995) · Infectious Diseases in Clinical Practice · doi:10.1097/00019048-199505000-00007 · Cited by 44
Primary Cutaneous Mucormycosis Caused by Rhizomucor variabilis in an Immunocompetent Patient
Ying, Z., Zhang, Q., Li, L., Zhu, J., Kang, K., & Chen, L. (2009) · Mycopathologia · doi:10.1007/s11046-009-9219-3 · Cited by 44
Schlemmer, F., Lagrange-Xélot, M., Lacroix, C., de Latour, R. P., Socié, G., & Molina, J. (2008) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.199 · Cited by 42
Posaconazole Prophylaxis in Experimental Systemic Zygomycosis
Barchiesi, F., Spreghini, E., Santinelli, A., Fothergill, A. W., Pisa, E., Giannini, D., Rinaldi, M. G., & Scalise, G. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00969-06 · Cited by 39
Simitsopoulou, M., Roilides, E., Maloukou, A., Gil‐Lamaignere, C., & Walsh, T. J. (2007) · Mycoses · doi:10.1111/j.1439-0507.2007.01457.x · Cited by 37
Rhino-orbito-cerebral mucormycosis☆☆☆★
Bendet, E., Talmi, Y. P., & Kronenberg, J. (1996) · Otolaryngology · doi:10.1016/s0194-5998(96)70112-2 · Cited by 37
Soummer, A., Mathonnet, A., Scatton, O., Massault, P. P., Paugam, A., Lemiale, V., Mira, J. P., Dannaoui, É., Cariou, A., & Lortholary, O. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01611-07 · Cited by 36
Self-citationChaves, M. M., Silvestrini, A. A., Silva-Teixeira, D. N., & Nogueira-Machado, J. A. (1996) · Inflammation Research · doi:10.1007/bf02252942 · Cited by 36
Immunomodulation of invasive fungal infections
Roilides, E., Lyman, C. A., Panagopoulou, P., & Chanock, S. J. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(02)00070-3 · Cited by 34
Breakthrough zygomycosis on posaconazole prophylaxis after allogeneic stem cell transplantation
Mousset, S., Bug, G., Heinz, W., Tintelnot, K., & Rickerts, V. (2009) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2009.00479.x · Cited by 33
Determination of MICs of Aminocandin for Candida spp. and Filamentous Fungi
Isham, N. C., & Ghannoum, M. A. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01550-06 · Cited by 32
Eisen, D. P., & Robson, J. (2004) · Mycoses · doi:10.1111/j.1439-0507.2004.00959.x · Cited by 31
Cordonnier, C., Bresnik, M., & Ebrahimi, R. (2007) · Mycoses · doi:10.1111/j.1439-0507.2007.01362.x · Cited by 28
Gil‐Lamaignere, C., Hess, R., Salvenmoser, S., Heyn, K., Kappe, R., & Müller, F. C. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki140 · Cited by 26
García-Covarrubias, L., Barratt, D. M., Bartlett, R. H., et al. (2004) · PubMed · Cited by 25
García-Covarrubias, L., Barratt, D. M., Bartlett, R., et al. (2004) · Revista de investigaci�n Cl�nica · Cited by 17
Forty-One Recent Cases of Invasive Zygomycosis From a Global Clinical Registry.
Rüping, M., Heinz, W., Kindo, A. J., Rickerts, V., Lass‐Flörl, C., Beisel, C., Herbrecht, R., Roth, Y., Silling, G., Ullmann, A. J., et al. (2009) · Blood · doi:10.1182/blood.v114.22.4736.4736 · Cited by 15
Self-citationKrishnan-Natesan, S., Manavathu, E. K., Alangaden, G. J., & Chandrasekar, P. H. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.12.013 · Cited by 13
Assessing Responses to Treatment of Opportunistic Mycoses and Salvage Strategies
Wirk, B. M., & Wingard, J. R. (2011) · Current Infectious Disease Reports · doi:10.1007/s11908-011-0217-5 · Cited by 4
(1998) · doi:10.1002/(sici)1096-8652(199801)57:1<7::aid-ajh2>3.0.co;2-0
Cited by
Cornely, O. A., Alastruey-Izquierdo, A., Arenz, D., Chen, S. C. A., Dannaoui, E., Hochhegger, B., Hoenigl, M., Jensen, H. E., Lagrou, K., Lewis, R. E., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30312-3 · Cited by 1,820
Self-citationTissot, F., Agrawal, S., Pagano, L., Petrikkos, G., Groll, A. H., Skiada, A., Lass-Flörl, C., Calandra, T., Viscoli, C., & Herbrecht, R. (2017) · Haematologica · doi:10.3324/haematol.2016.152900 · Cited by 682
Self-citationAlanio, A., Hauser, P. M., Lagrou, K., Melchers, W. J. G., Helweg-Larsen, J., Matos, O., Cesaro, S., Maschmeyer, G., Einsele, H., Donnelly, J. P., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw156 · Cited by 417
Groll, A. H., Castagnola, E., Cesaro, S., Dalle, J.-H., Engelhard, D., Hope, W., Roilides, E., Styczynski, J., Warris, A., & Lehrnbecher, T. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70017-8 · Cited by 407
Self-citationPopulation-Based Survey of Filamentous Fungi and Antifungal Resistance in Spain (FILPOP Study)
Alastruey-Izquierdo, A., Mellado, E., Peláez, T., Pemán, J., Zapico, S., Alvarez, M., Rodríguez-Tudela, J. L., Cuenca-Estrella, M., & FILPOP Study Group (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00383-13 · Cited by 276
Metadata
- Authors
- Skiada, A., Lanternier, F., Groll, A. H., Pagano, L., Zimmerli, S., Herbrecht, R., Lortholary, O., Petrikkos, G. L., & Leukemia*, O. B. O. T. T. E. C. O. I. I.
- Venue
- Haematologica
- Published
- 2012-09-14
- Volume
- 98
- Issue
- 4
- Pages
- 492-504
- ISSN
- 0390-6078 (ISSN-L)
- 1592-8721
- OpenAlex
- W2130747595
- Cited by
- 372
- References
- 111
- FWCI
- 17.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.